KYORIN Pharmaceutical Co., Ltd.【JP:4569】Cash flow
Market cap
¥103.3B
P/E ratio
19.1x
| 2015/03 | 2016/03 | 2017/03 | 2018/03 | 2019/03 | 2020/03 | 2021/03 | 2022/03 | 2023/03 | 2024/03 | 2025/03 | |
| Depreciation & amortization | 3,053 | 3,730 | 3,619 | 3,644 | 2,940 | 3,221 | 3,564 | 3,714 | 3,840 | 4,290 | 4,603 |
| Cash from operations | 6,391 | 11,137 | 16,386 | 10,456 | 340 | 7,739 | 5,189 | 6,346 | 2,008 | 1,549 | 3,506 |
| Capital expenditures | -5,383 | -6,812 | -2,208 | -3,387 | -2,170 | -2,624 | -4,067 | -2,444 | -6,330 | -5,778 | -5,697 |
| Cash from investing | -1,364 | 650 | -13,142 | -6,038 | 14,939 | -2,943 | -4,259 | -2,560 | -6,275 | -3,187 | -6,323 |
| Payments for dividends | -4,626 | -3,876 | -4,322 | -4,325 | -5,068 | -4,346 | -4,347 | -3,767 | -3,015 | -3,013 | -3,015 |
| Proceeds from issuance of term debt, net | 2,227 | 2,853 | 916 | 1,712 | 303 | 10,180 | - | - | - | - | 20,000 |
| Repayments of term debt | -308 | -764 | -1,153 | -1,297 | -1,582 | -832 | -428 | -200 | -200 | -200 | -10,200 |
| Cash from financing | -5,233 | -2,245 | -5,721 | -3,735 | -27,315 | -5,117 | -4,918 | -4,112 | -3,363 | -3,347 | 3,952 |